Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial
- 1 June 2017
- journal article
- research article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 44, 16-23
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Chronic obstructive pulmonary disease and sudden cardiac death: A systematic reviewTrends in Cardiovascular Medicine, 2016
- Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF TrialCardiology, 2016
- Are COPD and cardiovascular disease fundamentally intertwined?European Respiratory Journal, 2016
- Roflumilast: a review of its use in the treatment of COPDInternational Journal of Chronic Obstructive Pulmonary Disease, 2016
- Weaning from inhaled corticosteroids in COPD: the evidenceEuropean Respiratory Journal, 2015
- Knowing when to stop: inhaled corticosteroids and COPDEuropean Respiratory Journal, 2015
- Escalation and De-escalation of Therapy in COPD: Myths, Realities and PerspectivesDrugs, 2015
- Measuring the Global Burden of DiseaseNew England Journal of Medicine, 2013
- The association between COPD and heart failure risk: a reviewInternational Journal of Chronic Obstructive Pulmonary Disease, 2013
- Diagnostic and Therapeutic Challenges in Patients With Coexistent Chronic Obstructive Pulmonary Disease and Chronic Heart FailureJACC, 2007